Union Home Minister Amit Shah and Gujarat Chief Minister participated in the groundbreaking ceremony for this IPA-backed ...

Union Home Minister Amit Shah on Tuesday said the pharmaceutical sector is a strategic national asset that directly impacts ...

Pharma industry urges Budget reforms for R&D incentives, regulatory simplification, and enhanced healthcare spending to boost ...

India’s pharmaceutical exports reached $30.47 billion in FY 2024–25, registering a 9.4 per cent year-on-year growth, and are ...

In FY25, India's pharmaceutical exports reached a record high, surpassing $30 billion (approximately $30.47 billion), a ...

Sun Pharma's Managing Director, Kirti Ganorkar, predicts that new age medicines for obesity and diabetes will drive the growth of the domestic pharmaceutical industry.

The year also reinforced a long-standing strength of Indian pharma: its ability to scale through strategic consolidation.

India’s pharmaceutical exports reached US$ 30.47 billion in FY 2024–25, and the sector remains optimistic about further growth, driven by strong global demand and resilient production capabilities.

Indian speciality pharmaceutical firm Ajanta Pharma is understood to be eyeing a manufacturing operation in Ireland. The ...

In 2025, the BSE Healthcare Index which is represented by mostly pharma companies underperformed the Sensex, declining ...

From vitamin maker to pharmaceutical specialist and now contract manufacturer, India’s Lupin is embarking on a new phase of its corporate journey. Lupin on Monday unveiled its new subsidiary, Lupin ...

With the right policy support, the sector can reach a size of USD 120-130 billion by 2030, and expand further to about USD ...